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Summary The growth kinetics of established human colorectal tumour cell lines (HT29, HTI 15 and COLO
320DM) and human diploid fibroblasts (Flow 2002) were studied in conventional culture and in microcapsules
formed from alginate - poly(L-lysine) - alginate membranes. The tumour lines grew rapidly in microcapsules
but, in the case of the substrate-adherent lines HT29 and HTl 15, only after a prolonged lag phase. This phase
was reduced by serial passage in microcapsules. The anchorage-independent line COLO 320DM showed no
lengthening in lag phase. Microencapsulated fibroblasts underwent negligible growth but remained viable.
Some evidence for functional differentiation (microvilli, cell-cell junctions) of the tumour line HTl 15 within
the microcapsules was observed. We conclude that the use of microcapsules provides an alternative system
with some advantages for the study of human cancer and its metastases in vitro.
Current methods for the experimental study of human cancer
and its therapy involve the use of either tissue culture techni-
ques in vitro or animal models (Bateman et al., 1979) such as
the syngeneic tumour/animal system (Fidler, 1978) and the
xenografting of human tumors into immunodeficient mice
(Schmidt et al., 1977). All these systems have important
limitations in the prediction of the response of human
tumours to therapeutic intervention (Bailey et al., 1981;
Giovanella et al., 1983; Selby et al., 1983; Edelstein et al.,
1984), for instance the frequent difficulty encountered in
culturing tumour cells free from stromal cells, the poor acces-
sibility to manipulation of cultures growing in semi-solid
media and the slow rate with which many tumours grow in
nu/nu mice. While comparable with growth in the human
host, this rate is too slow for predictive testing, since it may
take 2-3 weeks before palpable tumour growth can be
detected at all.
The encapsulation of mammalian cells within alginate -
poly(L-lysine) - alginate membranes was first proposed by
Chang (Chang et al., 1966). Islets of Langerhans have been
successfully microencapsulated and used as allografts (Sun &
O'Shea, 1985) and as xenografts (O'Shea & Sun, 1986) to
alleviate diabetes and its complications in recipient animals.
The ability of the microcapsular membrane to immuno-
isolate xenografted cells has also been demonstrated (Darquy
& Reach, 1985). Recently the use of the microencapsulation
technology in cancer therapeutic studies using established
human tumour cell lines grown in immunocompetent animals
has been reported (Gorelick et al., 1987; Chen et al., 1988).
Our intention is to evaluate this technique for the culture of
primary human tumour material in vitro and in vivo but first
a basic understanding of the behaviour of established cell
lines in microencapsules and the extent to which this differs
from conventional culture must be acquired. Furthermore,
since most primary tumours are accompanied by stromal
cells, the behaviour of cells such as fibroblasts in this system
will be extremely important.
We have therefore investigated the growth in vitro of three
colorectal tumour cell lines, both substrate-adherent (HT29
and HT115) and nonadherent (COLO 320DM), a human
diploid fibroblast line (Flow 2002) and mouse NIH-3T3
fibroblasts in microcapsules. This was compared with their
growth in conventional culture.
Materials and methods
Materials
All tissue culture media were purchased from Gibco, foetal
calf serum from Biological Industries and plastic-ware from
Sterilin. Protanal LF 10/60 sodium alginate was from Protan
(Norway) and was given to us by Prof. G. Codd. Other
chemicals were purchased from Sigma. Cell lines HT29,
HT115 and COLO 320DM (all of human colorectal cancer
origin) were obtained from ECACC (Porton Down, UK) and
used within 12 passages of their arrival for the experiments
reported here. The human embryonic diploid fibroblast line
Flow 2002 was purchased from Flow Laboratories and used
at passage 18-25. Mouse NIH-3T3 fibroblasts were a gift
from Prof. B. Burchell.
Cell culture conditions
Stock cultures were passaged in 75 cm2 flasks in a standard
medium consisting of a 1:1 mixture of Dulbecco's modified
Eagle's medium and Ham's F12 nutrient medium, to which
was added 10% heat-inactivated foetal calf serum, 2 mM
L-glutamine, 50 U ml-' penicillin G and 50 tg ml-' strep-
tomycin. Cultures were maintained at 37°C, 5% C02, 100%
relative humidity and growth medium was replenished as
necessary. Adherent cell populations approaching 90%
confluence were harvested with trypsin/EDTA and subcul-
tured. COLO 320DM cells, which are very weakly adherent,
were gently shaken into suspension before being recovered by
centrifugation.
Cell encapsulation procedure
A modification of the method of Lim and Sun (1980) based
on considerations of the permeability of the microcapsular
membrane (Shimi et al., 1991) was used. Briefly, the cells
were harvested, centrifuged at 1000 g for 10min, washed
three times in phosphate buffered saline and resuspended at a
final concentration of 2 x 106ml- in 1.8% (w/v) sodium
alginate. The suspension was then syringe-extruded through
the central needle of a co-axial needle assembly in which air
flowing through the peripheral needle sheared droplets of the
mixture at a specified diameter. These were collected in a
solution ofcalcium chloride in which they formed gel spheres
of calcium alginate. The surface of these spheres was electro-
complexed with the polycation poly(L-lysine) of mean M,
22,000 thus forming the semi-permeable membrane. The
remaining cationic charges on the surface of the spheres were
neutralised by a further coating with alginate and the interior
gel matrix of the microcapsules was then dissolved by chel-
ating the calcium ions in citrate. The capsules were washed
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thoroughly in normal saline, their sedimented volume was
estimated and they were placed in 10 volumes of culture
medium.
Microcapsule disruption
Microcapsules were transferred to a motor-driven glass/glass
Potter homogeniser and disrupted with three strokes of the
pestle.
Growth kinetics
(i) Monolayer or suspension culture Adherent lines were
cultivated in 24-well plastic plates. Half of the medium was
removed every 3 days and replaced by an equal amount of
fresh medium. Duplicate samples were harvested by trypsin/
EDTA treatment at intervals for up to 30 days. Cell suspen-
sions were diluted into counting medium and counted in a
model D Coulter counter (which was calibrated daily with
dextran beads and for each cell line by reference to calibra-
tion curves generated by parallel haemocytometer estima-
tions). COLO 320DM cells were grown in 75 cm2 T-flasks
and half of the medium was replaced every 3 days. Duplicate
2 ml samples of the cell suspension were removed after gentle
shaking of the flask, added to 100 ml counting fluid and
Coulter counted.
(ii) Microcapsules Following encapsulation, cell lines were
cultured as 10% (packed volume of capsules:volume of
medium) suspensions in nutrient medium in 75 cm2 flasks.
Half of the medium was replaced every 3 days. Duplicate
1.0 ml samples of resuspended capsules were taken, the cap-
sules were disrupted as described above and the homogenate
was diluted to 100ml for Coulter counting.
Growth morphology
The microcapsules and conventional cultures were observed
by phase-contrast microscopy prior to counting. Photographs
were taken on an Olympus CK2 microscope fitted with a x 4
phase-contrast objective, a x 3.3 phototube and a Canon
35 mm camera body.
Serial passage in microcapsules
HT29, COLO 320DM and Flow 2002 cells were encapsulated
and cultured as described above. Cells were counted on
alternate days. After 14 days, 5 ml of each suspension were
removed, homogenized and filtered through 50 sm nylon
mesh to remove capsular debris. Viable cells were counted in
a haemocytometer with the addition ofTrypan blue and were
then suspended in the appropriate amount of sodium alginate
to achieve a suspension of 2 x 106 cells per ml. This was
immediately re-encapsulated and placed into fresh medium
as a 10% (vol/vol) culture. Further cell growth was recorded
on alternate days and the same recovery/encapsulation
process repeated another two times (four passages in
total).
Electron microscopy
Microcapsules containing HTI 15 cells were cultured for 7
days and then fixed in 3% glutaraldehyde, 0.2 M cacodylate
pH 7.2. They were post-fixed in osmium tetroxide and em-
bedded for sectioning in Araldite. Thin sections were stained
with uranyl acetate and lead citrate and examined in a JEOL
100CX electron microscope at 60 kV.
Results
Growth kinetics
The initial seeding densities and important growth para-
meters are summarised in Table I. Encapsulation of the two
Table I Cell growth parameters
Line Seeding density lag (d) doubling tinm (d)
A: Conventional culture
HT29 2.5 x 105cm-2 0 5.7
HTII5 0.3 x 105cMu2 0 2.6
COLO 1.0 x 105 ml' 3.6 4.2
Flow 8.0 x 104cm-2 0 2
B: Microcapsules
HT29 2.0x 105ml-' 9 3.2
HTII5 2.6x 105ml1 11 4.7
COLO 1.0x105ml-' 1 3.3
Flow 8.0 x 104ml-' 15 >30
COLO: COLO 320DM colorectal tumour cells. Flow: Flow 2002
diploid fibroblasts. The initial rapid logarithmic growth phase ofeach
culture was analysed by linear regression. The lag was estimated from
thetimetaken toexceedtheseedingdensityandthedoublingtimefrom
the slope ofthe line.
anchorage-dependent colorectal tumour lines HT29 and
HT115 (Figure 1) resulted in a prolonged lag phase of 10
days. Growth thereafter was not impaired and indeed the
doubling times were slightly less than those in monolayer
culture. Both cell lines underwent an approximately 10-fold
expansion (from about 360 cells per capsule to about 3600).
In contrast, microencapsulation of the anchorage-indepen-
dent colorectal tumour line COLO 320DM had much less
effect on its growth parameters (Figure 2), indeed a slight
reduction in lag phase was observed. We conclude that the
lag-phase in the anchorage-dependent lines is unlikely simply
to be the result of nutrient starvation.
The normal diploid human fibroblast line Flow 2002 grew
extremely quickly in conventional culture, reaching
confluence in 5 days (the DMEM/F12 formulation is
generally regarded as being an optimal medium for fibroblast
culture). There was no significant growth in the microcap-
sules over the 30-day observation period (Figure 3), though
there is a very slight upward trend. Their viability after this
period was confirmed by disrupting the capsular membrane
and releasing the cells into culture medium in flasks. They
then grew with kinetics and morphology similar to those of
standard monolayer preparations. Similar data were obtained
using the mouse NIH3T3 fibroblast line (data not shown),
indicating that the effect is not confined to the human fibro-
blast line we have chosen to study.
Cellular morphology
Microencapsulated human colorectal tumour cell lines grew
in 3-dimensions (Figure 4). After the interior calcium alginate
gel matrix had been dissolved in citrate, the majority of the
cells sedimented to the trough of the hollow capsule (except
those entrapped by the capsular membrane). Subsequent
growth was in several clusters arising from aggregates of
encapsulated cells. Fibroblasts also formed clumps, but these
did not then expand.
Serialpassage in microcapsules
Serial passage of the tumour lines HT29 and COLO 320DM
in microcapsules resulted in a significant reduction in the lag
phase. This was observed after one passage and was most
pronounced after two (Figure 5). That for HT29 decreased
from 10 days to 4 days and that for COLO 320DM from 3
days to 1 day. The doubling times remained essentially
unaltered during the course of the experiment. Some evidence
for a re-introduction of the lag phase was visible in the
fourth passage (Figure Sa).
The cells were released into conventional culture after the
fourth passage. The COLO 320DM cells continued to grow
in clusters in suspension but HT29 cells grew initially as
distinct colonies consisting of a central multilayered adherent
cluster of cells from which peripheral cells migrated to cover
the surface of the flask (data not shown).MICROENCAPSULATED TUMOUR CELLS 677
Microencapsulated fibroblasts showed no significant
growth in serial microcapsule passages (Figure 5c). They
remained viable however and when they were released from
the fourth microcapsular passage, they grew in conventional
culture, though initially with a tendency to form clumps.
With further passage, they regained their original monolayer
growth morphology (data not shown).
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Figure 2 Growth of the anchorage-independent colorectal tu-
mour cell line COLO 320DM in suspension culture (a) and in
10% microcapsular culture (b).
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Figure 1 Growth of substrate-adherent colorectal tumour cell
lines. HT29 in monolayer (a) and microcapsule (b) cultures.
HTl15 (c,d) in the same conditions. Duplicate cell counts were
carried out using a Coulter counter. The values for the microcap-
sular cultures are expressed per ml of medium (i.e. per 0.1 ml of
packed capsules).
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Figure 3 Growth of the human fibroblast line Flow 2002 in
monolayer (a) and in 10% microcapsular culture (b).
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Figure 4 Established cell lines after 21 days in microcapsular
culture. (1) HT29 colorectal tumour cell line, (2) HT115 colorec-
tal tumour cell line, (3) COLO 320DM colorectal tumour cell line
and (4) human fibroblast cell line Flow 2002. Cultures were
photographed on the phase contrast microscope. The capsules are
approximately 0.5 mm in diameter.
Ultrastructure ofencapsulated cells
Microencapsulated cells were cultured for various periods
and then processed for transmission electron microscopy.
This revealed generally good cell viability (Figure 6) even in
cultures which had not begun to multiply (Figure 6a, HT115
substrate-dependent cells) and which would never grow (Fig-
ure 6c, Flow 2002 fibroblasts). At higher magnification,
HT115 cells demonstrated some differentiative features, such
as microvilli and junctional complexes between cells (Figure
6d).
Discussion
Our results indicate that the anchorage-dependent cell lines
HT29 and HT115 take much longer to begin dividing when
first microencapsulated but thereafter grow slightly faster
than monolayer cultures. The capsular membrane therefore
cannot be preventing adequate entry of nutrients and growth
factors from the surrounding medium. The prolonged lag
phase could arise as a result either of adaptation of the
general cell population to the new environment or of selec-
Figure 5 Senal passage (P1 -P4) of tumour and normal cell lines
in microcapsules. a; HT29. b; COLO 320DM. c; Flow 2002. Cells
were microencapsulated and counted as described. After 14 d, a
sample of the culture was taken, the microcapsules disrupted and
a fraction of the released cells re-encapsulated for the next pas-
sage.
tion of a pre-existent minority of cells capable of prolifera-
tion in this environment. Formal proof must await the isola-
tion of truly clonal lines form the parent HT29 but the
adaptation hypothesis more easily explains the ease with
which the cells revert to monolayer culture once they are
removed from the capsules. Once the adaptation has occur-
red, further passages in capsules show a much reduced lag
phase. Other workers have reported very poor growth of
transformed anchorage-dependent cells in microcapsules
(Young et al., 1989). They also showed that growth was
restored by co-encapsulating shards of gelatin which acted as
a cell substrate. Our results indicate that some cell lines,
generally considered to be anchorage-dependent, can adapt
to the capsular environment, even in the absence of a gelatin
substrate.
The anchorage-independent colorectal tumour cell line
COLO 320DM behaved very similarly in free suspension and
in microcapsules. The cells showed little tendency to form
strong cell-cell or cell-substrate interactions in either system.
These results are entirely consistent with the work of other
laboratories demonstrating rapid growth of myeloma and
lymphoma cell lines in microcapsules. We did note a slight
reduction in lag phase on microcapsular passage of these
cells. It is possible that selection for, or adaptation toward,
autocrine stimulation might be involved in this phenomenon.
Neither the normal human diploid fibroblast line Flow
2002 nor mouse NIH3T3 cells grew significantly in microcap-
sules, even after repeated passage. They remained viable after
four microcapsular subcultures, indicating that the encapsula-
tion procedure is not toxic to them. The most likely explana-
tion is the extreme dependence of proliferation on successful
adherence to, and spreading on, a substrate.
Overall, our results are similar to those to be expected in
semi-solid agar (Selby et al., 1983). The Flow 2002 fibroblasts
also grow at low efficiency in this medium (data not shown),
suggesting a common mechanism of inhibition (though con-
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Figure 6 Electron micrographs of cells cultured in microcapsules. The black bar on each photograph represents 1 Am. (a) HTI 15
colorectal tumour cells cultured for 5 days. Note the variation in electron density in the capsular wall. (b) COLO 320DM tumour
cells cultured for 9 days. (c) Flow 2002 fibroblasts cultured for 30 days. (d) A higher-magnification view of HTI 15 cells. Note the
formation of microvilli and junctional complexes between adjacent cells.
centration of autocrine growth-inhibitory substances within
the capsules cannot yet be ruled out). However, microencap-
sulation provides much easier access to the cells in that
macromolecules of MW up to about 60,000 freely diffuse
across the membrane (Shimi et al., 1991). In addition, the
cells may be recovered and re-passaged or transferred to
conventional culture. This will allow future experiments to
determine which factors may promote fibroblast growth and
to examine the molecular events required in the lag phase of
tumour cell culture.
Electron microscopy demonstrates tight junctions between
cells and some evidence of differentiation in microcapsular
cultures. We have not yet examined this phenomenon in
detail but ultrastructural studies of these cells growing in
monolayers, semi-solid media and microcapsules are in pro-
gress. In the meantime, we are encouraged that some mic-
rocapsular cultures show properties similar to those of gas-
trointestinal epithelial cells in vivo.
In summary, we have demonstrated that established tu-
mour cell lines, whether anchorage-dependent or anchorage-
independent, can adapt rapidly to growth inside microcap-
sules. Three-dimensional structures are formed and electron-
microscopic features characteristic of intestinal epithelia can
be observed. Microcapsular culture strongly selects against
the proliferation of fibroblasts. We believe that this system
will have significant advantages for the culture of primau
human tumour material where these preparations of geo
etry and selection will be important. In addition, by offering
the possibility of switching between monolayer and three-
dimensional culture in vitro, it will be useful for the study of
the relationship between geometry and expression of cell-cell
adhesive properties and immunological markers of
differentiation.
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